Search This Blog

De Omnibus Dubitandum - Lux Veritas

Saturday, September 12, 2020

A Tale of Two COVID Treatments

September 11, 2020 By Brian C. Joondeph, M.D.

 COVID-19 is a nasty virus, damaging or killing the unfortunate few who caught it and became extremely ill. Preferring the elderly and those with preexisting medical conditions, many died or had their lives and families upended.

Far more have been ravaged by the downstream effects of the Wuhan virus - socioeconomic destruction following the economic shutdown which persists to this day in many locales as well as delayed or deferred medical care from a several month-long ban on elective medical care.

Deaths and hospital resource use peaked in mid-April nationally, with occasional local resurgences, generally mild and short-lived, yet in September many schools remain closed, large gatherings prohibited, businesses shuttered, and masks remain the fall season’s fashion accessory.

There are only a few ways out of this quagmire. Herd immunity has been the traditional endpoint for past viral pandemics as it occurs relatively quickly. Sweden has likely achieved herd immunity without shutting down as did their neighbors.

Israeli Professor Isaac Ben-Israel used statistical analysis demonstrating, “The spread of COVID-19 peaks after about 40 days and declines to almost zero after 70 days — no matter where it strikes, and no matter what measures governments impose to try to thwart it.”

Other options include therapeutics or a vaccine. Viruses are notoriously difficult to cure with medications. Vaccines provide varying degrees of protection against viruses but take many months or years to develop and earn FDA approval..........To Read More....

No comments:

Post a Comment